İnflamatuar Barsak Hastalıkları

inflamatuar barsak hastalıkları İBH , gastrointestinal kanalın kronik, idyopatik inflamasyonu ile karakterize hastalıklardır; Crohn hastalığı CH ve ülseratif kolit ÜK olmak üzere iki major klinik formdan oluşur. Ayırıcı tanının klinik, radyolojik, endoskopik ve histolojik özellikleri bazında yapılması, uygun kritik tedavi yaklaşımlarının farklı olduğu durumlarda özellikle önemlidir. Makroskopik ve mikroskopik olarak her iki hastalığa ait özellikleri de taşıdığı için net olarak sınıflandırılamayan, olguların % 10-15’ini oluşturan klinik durum “indeterminate kolit” olarak nitelenmektedir.

PDF

___

1. Griffiths A.M. , Buller H.B. Inflammatory Bowel Disease In: Walker, Durie, Hamilton (eds). Pediatric Gastrointestinal Disease 3rd edition. Ontario: B.C. Decker Inc; 2000: 613- 52.
2. Hyams JS. Crohn’s Disease In: Willie/Hyams (eds). Pediatric Gastrointestinal Disease. 2nd edition. Philadelphia W.B. Saunders Company; 1999: 401- 18.
3. Markowitz. JF. Ulcerative Colitis. In: Willie/ Hyams (eds). Pediatric Gastrointestinal Disease. 2nd edition Philadelphia: W.B. Saunders Company; 1999: 419- 32.
4. Ulshen M. Inflammatory Bowel Disease In: Behrman, Kliegman (eds). Nelson Textbook of Pediatrics. 15th edition. Philadelphia: W.B. Saunders Company; 1996: 1080-87.
5. Büller H. Inflammatory Bowel Disease and Genetics. The 36th Annual Meeting of Esphgan. Post-Graduate Course Book Prag; 4 Haziran 2003: 39-48.
6. Duerr RH. The Genetics of Inflammatory Bowel Disease. Gastroenterol. Clin. North Am. 2002; 31(1): 63- 76.
7. Krishnan A.,Joshua R. Inflammatory bowel disease and environmental influences. Gastroenterol. Clin. North Am. 2002; 31(1): 21- 39.
8. Abbas AK, Lithman AH, Pober JS. Immunity to Microbes. I: Cellular and Molecular Immunology 4th edition. Philadelphia: W.B. Saunders Company; 2000: 343- 467.
9. Plevy S. The immunology of inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31(1): 77- 92.
9a. Itoh J., Strong SA. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn’s disease. Gut 2001; 49: 35- 4.
10. Cuffary C., Darbari A. Inflammatory bowel disease in the pediatric and adolescent patient. Gastroenterol. Clin. North Am. 2002; 31(1): 275- 91.
11. Özkan T. Inflamatuar Barsak Hastal›klar›: Klinik Bulgular ve Tan› V. Ulusal Pediatrik Gastroenteroloji ve Beslenme Kongresi Kitab›. ‹stanbul; (6-8 Kas›m) 2002: 33- 36.
12. Kaymakoğlu S. Inflamatuar Barsak Hastalıkları. In: Ökten A., Mungan Z., Çakaloğlu Y.(eds). Gastroenterohepatoloji. istanbul; 2001: 189- 211.
13. Chinyu GS. Extraintestinal Manifestations of Inflammatory Bowel Disease. Gastroenterol. Clin. North Am. 2002; 31(1): 307- 28.
14. Carucci LR, Levine MS. Radiographic Imaging of Inflammatory Bowel Disease . Gastroenterol. Clin. North Am. 2002; 31(1): 93- 118.
15. Medical therapy of inflammatory bowel disease. Digestion 1998; 59: 453- 69.
16. Sökücü S. Kronik inflamatuar barsak hastalıklarında tedavi. V. Ulusal Pediatrik Gastroenteroloji ve Beslenme Kongresi Kitabı. İstanbul; 6-8 Kasım 2002: 37- 43
17. Fernandez- Banares F: How effective is enteral nutrition in inducing clinical remission in active Crohn’s disease? A meta- analysis of the randomized clinical trials. J Pediatr Gastroenterol Nutr 1995; 19: 356- 62.
18. Graham TO., Kandil HM., Nutritional factors in inflammatory bowel disease. Gastroenterol. Clin. North Am. 2002; 31(1): 203- 18.
19. Lochs H: Comparison of enteral nutrition and drug treatment in active Crohn’s disease. Results of the European Cooperative Crohn’s Disease Study IV. Gastroenterology 1995; 101: 881- 89.
20. Blumberg D, Beck DE. Surgery for ulcerative colitis. Gastroenterol. Clin. North Am. 2002; 31(1): 219- 35.*

Başlangıç: 2003
Yayıncı: Erkan Mor

Arşiv